A Study Evaluating The Pharmacokinetics, Pharmacodynamics And Safety Of Prasugrel Monotherapy In Healthy Japanese Elderly And Non-Elderly Subjects
Latest Information Update: 24 Apr 2017
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes; Stroke
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 24 Apr 2017 New trial record
- 17 Apr 2017 Results published in the Clinical Drug Investigation.